Literature DB >> 10992812

Korean Nationwide Surveillance of Antimicrobial Resistance of Bacteria in 1998.

K Lee1, C L Chang, N Y Lee, H S Kim, K S Hong, H C Cho.   

Abstract

Antimicrobial resistance surveillance can provide information needed for empirical therapy of antimicrobial agents and for control of resistance. To determine the trend of antimicrobial resistance in Korea, in vitro susceptibility data in 1998 were collected from 25 hospitals participating to a program of Korean Nationwide Surveillance of Antimicrobial Resistance (KONSAR). The data were analyzed based upon hospital location and bed capacity. The results showed that cefoxitin-resistant E. coli and K. pneumoniae and 3rd-generation cephalosporin-resistant K. pneumoniae were prevalent, that 3rd-generation cephalosporin-resistant E. cloacae, S. marcesens and A. baumannii had increased, and ampicillin-resistant S. enterica were not rare. Oxacillin-resistant S. aureus, penicillin-non-susceptible pneumococci and beta-lactamase-producing H. influenzae were prevalent even smaller hospitals surveyed, and an increase of imipenem-resistant P. aeruginosa and vancomycin-resistant E. faecium is a new obvious threat. In general, resistance rates to some old antimicrobial agents, i.e., E. coli to ampicillin and S. aureus to oxacillin were high and did not vary greatly between the different levels of hospitals, while the rates to some of the newer ones, i.e., P. aeruginosa to imipenem, was quite variable and depended on the hospitals, probably reflecting difference in selective pressure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10992812     DOI: 10.3349/ymj.2000.41.4.497

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  9 in total

1.  In vitro activities of DA-7867, a novel oxazolidinone, against recent clinical isolates of aerobic and anaerobic bacteria.

Authors:  Dongeun Yong; Jong Hwa Yum; Kyungwon Lee; Yunsop Chong; Sung Hak Choi; Jae Keol Rhee
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

2.  In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea.

Authors:  Jong Hwa Yum; Chang Ki Kim; Dongeun Yong; Kyungwon Lee; Yunsop Chong; Cheol Min Kim; Jeong Mi Kim; Seonggu Ro; Joong Myung Cho
Journal:  Antimicrob Agents Chemother       Date:  2007-04-09       Impact factor: 5.191

3.  Evaluation of efficiency of screening extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in hospitals where the bacteria are increasingly prevalent.

Authors:  K Lee; J K Lim; D Yong; J Yum; Y Chong; R Okamoto; M Inoue
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

4.  Nationwide surveillance for Staphylococcus aureus with reduced susceptibility to vancomycin in Korea.

Authors:  Hong Bin Kim; Wan Beom Park; Ki Deok Lee; Young Joo Choi; Sang Won Park; Myoung-Don Oh; Eui-Chong Kim; Kang Won Choe
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

5.  Alterations of gyrA, gyrB, and parC and Activity of Efflux Pump in Fluoroquinolone-resistant Acinetobacter baumannii.

Authors:  Sunok Park; Kyeong Min Lee; Yong Sun Yoo; Jung Sik Yoo; Jae Il Yoo; Hwa Su Kim; Yeong Seon Lee; Gyung Tae Chung
Journal:  Osong Public Health Res Perspect       Date:  2011-12

6.  Expression of Sme efflux pumps and multilocus sequence typing in clinical isolates of Stenotrophomonas maltophilia.

Authors:  Hye Hyun Cho; Ji Youn Sung; Kye Chul Kwon; Sun Hoe Koo
Journal:  Ann Lab Med       Date:  2011-12-20       Impact factor: 3.464

7.  Impact of COVID-19 on Antimicrobial Consumption and Spread of Multidrug-Resistance in Bacterial Infections.

Authors:  Kibum Jeon; Seri Jeong; Nuri Lee; Min-Jeong Park; Wonkeun Song; Han-Sung Kim; Hyun Soo Kim; Jae-Seok Kim
Journal:  Antibiotics (Basel)       Date:  2022-04-18

8.  Sccmec type II gene is common among clinical isolates of methicillin-resistant Staphylococcus aureus in Jakarta, Indonesia.

Authors:  Latre Buntaran; Mochammad Hatta; Andi R Sultan; Ressy Dwiyanti; Muhammad Sabir
Journal:  BMC Res Notes       Date:  2013-03-23

9.  Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial.

Authors:  Jong Wook Kim; Joowon Chung; Sang-Ho Choi; Hang Jea Jang; Sang-Bum Hong; Chae-Man Lim; Younsuck Koh
Journal:  Crit Care       Date:  2012-02-15       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.